13F-HR filed by Indaba Capital Management, L.P.
Indaba Capital Management, L.P. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 7 holding rows worth $154,899,088.
- Accession
- 0001011438-24-000459
- Filer
- CIK 1524362
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 7 entries on the cover page, a total value of $154,899,088 stated on the cover page (in dollars after the unit check, H1), rows summing to $154,899,088 with VALUE read as dollars as filed, 13F file number 028-16058. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EQUITY COMMONWEALTH | 294628102 | COM SH BEN INT | 2,700,000 | $52,380,000 | dollars as filed | |
| BANDWIDTH INC | 05988JAD5 | NOTE 0.500% 4/0 | 49,250,000 | $36,986,750 | dollars as filed | principal |
| ON24 INC | 68339B104 | COM | 4,240,256 | $25,483,939 | dollars as filed | |
| BLACKLINE, INC. | 09239B109 | COM | 292,000 | $14,147,400 | dollars as filed | |
| XOMETRY INC | 98423FAB5 | NOTE 1.000% 2/0 | 17,750,000 | $13,371,075 | dollars as filed | principal |
| ACCELERATE DIAGNOSTICS INC | 00430HAC6 | NOTE 5.000%12/1 | 24,083,901 | $11,603,624 | dollars as filed | principal |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 1,000,000 | $926,300 | dollars as filed | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001011438-24-000459 | this filing | 2024-08-14 | acceptance time not in the bulk data set |